Experimental antibody targets deadly staph infections
Disease control
Completed
This study tested a lab-made antibody called 514G3 in 52 hospitalized adults with Staphylococcus aureus bloodstream infections. Participants received either a single dose of the antibody plus standard antibiotics or a placebo plus antibiotics. The main goals were to check safety …
Phase: PHASE1, PHASE2 • Sponsor: XBiotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC